A 12-Week Trial Measured What a 10% Vitamin C Serum Does to Glycation Markers

Almost every vitamin C claim is an antioxidant claim. A trial published in the Journal of Cosmetic Dermatology went looking for something else: whether a topical serum shifts the markers of glycation, the reaction in which sugars attach themselves to structural proteins and leave them stiffer than they were.

Sixty-six healthy Chinese women took part, split into 35 who applied a 10 percent vitamin C serum and 31 who acted as controls. The trial ran 12 weeks and measured biochemical markers rather than asking participants how their skin looked to them.

The reported movements are large. Advanced glycation end products fell by 17.65 percent. Carbonylation, read as fluorescence intensity, dropped by 49.22 percent. Interleukin-1 alpha, an inflammatory signalling molecule, came down by 58.73 percent. Free radical scavenging capacity rose by 12.14 percent, and measured yellowness and redness fell by 6.13 and 16.46 percent respectively.

Instrumented endpoints are a real step up from the consumer self-assessment panels that most serum marketing rests on, and the authors declared no competing interests. That is a better evidential footing than the industry-sponsored norm in this category.

The limits are just as plain. One ethnic group in one country, sixty-six people in total, and no product named, so there is no telling which 10 percent formulation this was, what pH it held or how it was packaged. A percentage change in a fluorescence reading is also not the same thing as a visible difference in a mirror. The study measures mechanism, not satisfaction.

Read next to the 2026 reformulations that have begun adding carnosine and neohesperidin specifically to target glycation, it hints that the vitamin C already in the bottle may have been doing some of that job. It does not tell you how much of the effect survives outside a controlled study.